Document:

Exhibit 10.8

 

Social Capital Hedosophia Holdings
Corp.

120 Hawthorne Avenue

Palo Alto, CA 94301

 

                   ,
2017

[           ]

[           ]

[           ]

 

Re: Administrative Services Agreement

 

Gentlemen:

 

This letter agreement by and between Social
Capital Hedosophia Holdings Corp. (the “Company”) and [           ]
(the “Provider”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities
of the Company are first listed on the New York Stock Exchange (the “NYSE”) (the “Listing Date”), pursuant
to a Registration Statement on Form S-1 and prospectus filed with the Securities and Exchange Commission (the “Registration
Statement”) and continuing until the earlier of the consummation by the Company of an initial business combination or the
Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to
as the “Termination Date”), the Provider, an affiliate of our sponsor, SCH Sponsor Corp., shall make available to the
Company, at 120 Hawthorne Avenue, Palo Alto, CA 94301 (or any successor location or other existing office locations of the Provider
or any of its affiliates), certain office space, administrative and support services as may be reasonably required by the Company.
In exchange therefor, the Company shall pay the Provider the sum of $10,000 per month on the Listing Date and continuing monthly
thereafter until the Termination Date.

 

The Provider hereby irrevocably waives any
and all right, title, interest, causes of action and claims of any kind (each, a “Claim”) in or to, and any and all
right to seek payment of any amounts due to it out of, the trust account established for the benefit of the public shareholders
of the Company and into which substantially all of the proceeds of the Company’s initial public offering will be deposited
(the “Trust Account”), and hereby irrevocably waives any Claim it may have in the future as a result of, or arising
out of, this letter agreement, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies
or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim
against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever.

 

This letter agreement constitutes the entire
agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements,
or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter
hereof or the transactions contemplated hereby.

 

     

     

    

 

This letter agreement may not be amended,
modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

 

No party hereto may assign either this letter
agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any
purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any
interest or title to the purported assignee.

 

Any litigation between the parties (whether
grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant
to the laws of the State of New York, without giving effect to its choice of laws principles.

 

This letter agreement may be executed in
one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute
one and the same letter agreement.

 

[Signature page follows]

 

 

     

     

    

Very truly yours,

 

 

 

SOCIAL CAPITAL HEDOSOPHIA HOLDINGS CORP.

 

By:                                                                                                        

Name:

Title:

 

AGREED TO AND ACCEPTED BY:

 

[         ]

 

By:                                                                                                        

Name:

Title:Exhibit 10.1

 

AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT

 

This Amendment
to EXECUTIVE Employment Agreement (this “Amendment”) is made and entered as of this 29th day of August,
2017, (the “Amendment Effective Date”) by and between Alliqua Biomedical, Inc., a Delaware corporation (the
“Company”), and David Johnson (“Executive”) for purposes of amending that certain Executive
Employment Agreement dated as of February 4, 2013 by and between Alliqua, Inc. and Executive (the “Agreement”).
Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed
to such terms in the Agreement.

 

WHEREAS, Section
10(k) of the Agreement provides that the parties to the Agreement may amend the Agreement in a writing signed by the parties; and

 

WHEREAS, the parties
hereto desire to amend the Agreement in certain respects.

 

NOW THEREFORE, pursuant
to Section 10(k) of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged, the
Company and Executive agree as follows:

 

1.             As
applicable, any and all references in the Agreement to “Alliqua, Inc.” shall be hereby amended by deleting each and
every said reference and substituting in lieu thereof the title of “Alliqua Biomedical, Inc.”

 

2.             Section
2 of the Agreement is hereby amended by deleting said section in its entirety and substituting in lieu thereof the following new
Section 2:

 

2.             Term
of Agreement. The Agreement’s stated term and the employment relationship created hereunder will remain in effect
until August 29, 2020, unless earlier terminated in accordance with Section 8.  This Agreement shall be automatically renewed
for successive one (1) year terms (each one-year period, a “Renewal Term”), unless Executive’s
employment is terminated by either party not less than four (4) months before August 29, 2020 or any Renewal Term, or unless earlier
terminated in accordance with Section 8.  The period during which Executive is employed under this Agreement (including any
Renewal Term) will be referred to as the “Employment Period.”

 

3.             Section
5(c) of the Agreement is hereby amended by deleting the phrase “Alliqua, Inc. 2011 Long-Term Incentive Plan and any amendments
thereto (the “2011 Plan”)” and replacing it with the “Alliqua, Inc. 2014 Long-Term Incentive
Plan, as it may be amended, and any successor plan thereto (the “Incentive Plan”)” and deleting
all references in said Section to the “2011 Plan” and replacing them with the “Incentive Plan”.

 

4.             Section
8 of the Agreement is hereby amended by deleting the lead-in paragraph of said section and substituting in lieu thereof the following
lead-in language:

 

8.             Termination
of Agreement. The employment relationship between Executive and the Company created under this Agreement shall terminate
upon the occurrence of any one of the following events:

 

5.             Section
9 of the Agreement is hereby amended by deleting said section in its entirety and substituting in lieu thereof the following new
Section 9:

 

     

     

    

 

9.             Compensation
Upon Termination for Any Reason. Upon the termination of Executive’s employment under this Agreement, Executive
shall be entitled to the following:

 

(a)           Termination
by the Company for Cause or as a Result of the Resignation of Executive Without Good Reason. In the event that Executive’s
employment is terminated either by the Company for Cause, or as a result of Executive’s resignation without Good Reason,
the Company shall, in addition to any benefits provided under any employee benefit plan or program of
the Company, pay the following amounts to Executive (or his estate or other legal representative, as the case may be) within
the time period required by applicable law (and in all events within thirty (30) days of such termination):

 

(i)         any
accrued but unpaid Base Salary (as determined pursuant to Section 5(a) hereof) for services rendered to the date of termination;

 

(ii)        any
accrued but unpaid expenses required to be reimbursed pursuant to Section 5(e) hereof; and

 

(iii)        any
earned, but unpaid, bonus under Section 5(b) for services rendered during the year preceding the date of termination.

 

The amounts described in Sections 9(a)(i)-(iii)
above, together with benefits provided under any employee benefit plan or program of the Company, shall
be referred to herein as the “Accrued Obligations.”

 

(b)           Termination
by Reason of Death or Disability of Executive. In the event that Executive’s employment is terminated by reason of Executive’s
death or Disability, the Company shall pay the following amounts to Executive (or his estate or other legal representative, as
the case may be) within the time period required by applicable law (and in all events within thirty (30) days of such termination):

 

(i)         the
Accrued Obligations; and

 

(ii)        notwithstanding
anything to the contrary in this Agreement with respect to the requirement of being employed as of December 31st, a
pro-rata portion (based on a fraction, the numerator of which is the number of days in the calendar year on which Executive performed
services prior to termination and the denominator of which is the number of days in such calendar year) of Executive’s annual
bonus that he would have earned had he been employed as of December 31st of the year in which his employment ends, but
calculated at the Target Bonus level (the “Pro-Rata Target Bonus”).

 

(c)           Termination
by the Company Without Cause, or by Executive for Good Reason. In the event that Executive’s
employment is terminated at any time during the Employment Period and such termination is initiated by the Company without Cause
or by Executive for Good Reason, the Company shall pay and/or provide
the following to Executive:

 

(i)         the
Accrued Obligations within the time period required by applicable law (and in all events within thirty (30) days of such termination);
and

 

    	 	2	 

     

    

 

(ii)        subject
to compliance with the restrictive covenants in Sections 6 and 7 and the execution and timely
return by Executive of a release of claims in substantially the form of Exhibit A hereto (the “Release”)
which the Company shall deliver to Executive within five (5) business
days following the termination of Executive’s employment, and subject to the provisions of Section 11 below:

 

(1)         The
Company shall pay Executive an amount equal to the sum of (x) two (2) years Base Salary and (y) two (2) years of Executive’s
annual bonus calculated at the Target Bonus level, less applicable taxes and other withholdings, payable
in twenty-four (24) equal monthly installments from the date of the termination of employment (the “Severance Period”);
provided, however, the Company shall pay (A) the number of installments that are exempt from Code section 409A as
short term deferrals under Treas. Reg. § 1.409A-1(b)(4) because they would have been paid during the short term deferral period
ending on the March 15th following the end of the calendar year that includes the date of Executive’s termination
of employment, plus (B) the number of installments that near or equal, but do not exceed, the dollar limit set forth in Treas.
Reg. § 1.409A-1(b)(9)(iii) (i.e., two (2) times the limit under Section 401(a)(17) of the Code) as of the date of Executive’s
termination of employment, in a single lump sum on the sixtieth (60th) day following the
termination of Executive’s employment, with the remainder of the installments being paid over the Severance Period on the
dates and in such amounts such installments would have been paid without regard to installments that were paid in a lump sum payment;

 

(2)         The
Company shall provide Executive and his dependents with continued healthcare coverage under the Company’s group health and
dental plans at the same cost, if any, imposed on active employees of the Company, until the earlier of (x) the expiration of the
Severance Period; (y) the date that Executive’s “COBRA” coverage terminates or expires; or (z) the date that
Executive obtains new employment that offers substantially similar health and dental coverage. Such continuing health and dental
coverage provided by the Company shall be provided pursuant to COBRA. To the extent any such benefits are otherwise taxable to
Executive, such benefits shall, for purposes of Section 409A of the Code, be provided as separate in-kind payments of those benefits,
and the provision of in-kind benefits during one calendar year shall not affect the in-kind benefits to be provided in any other
calendar year; and

 

(3)         notwithstanding
anything to the contrary contained in the Incentive Plan or in any predecessor or successor plan, award agreement, or similar equity
incentive scheme, any stock options and other equity-based awards granted to Executive that have not vested as of the date of termination
shall immediately become 100% vested and all restrictions shall lapse. All stock options vested prior to the date of termination
or which vest as a result of this Section 9(c)(ii)(3) shall remain exercisable for three (3) months following the expiration
of the Employment Period (unless the originally prescribed term of any such vested stock options expires sooner), in each case
as if Executive remained actively employed by the Company during such period.

 

    	 	3	 

     

    

 

In the event
Executive fails to comply with the restrictive covenants in Section 7 or does not timely execute
and return (or otherwise revokes) a release of claims in the form and substance reasonably requested by the Company, no amount
shall be payable to Executive pursuant to this Section 9(c)(ii).

 

6.             Section
10 of the Agreement is hereby amended to add the following new Section 10(o) to the Agreement:

 

(o)           Change
in Control. Notwithstanding anything to the contrary contained herein, in the event of a Change in Control (as defined in the
Incentive Plan, without giving effect to clause (v)(z) in such definition), provided that such Change in Control also constitutes
a change of control for purposes of Section 409A of the Code, the Company may, in its sole discretion and in accordance with Section
409A of the Code and Treas. Reg. § 1.409A-3(j)(4)(ix)(B), (i) terminate this Agreement and all agreements, methods, programs,
and other arrangements sponsored by the Company immediately after the Change in Control with respect to which deferrals of compensation
are treated as having been deferred under a single plan with the Agreement under Treas. Reg. § 1.409A-1(c)(2), effective as
of the date of the Change of Control, and (ii) subject to compliance with the restrictive covenants
in Sections 6 and 7 and the execution and timely return by Executive of a Release which the
Company shall deliver to Executive within five (5) business days of the Change in Control, pay,
in a single lump sum payment (A) on the date of the Change in Control the remaining unpaid portion of any payments and benefits
due under Section 9(c) if payments under Section 9(c) commenced prior to the Change in Control; or (B) within sixty (60) days of
the Change in Control the full amount of the payments and benefits due under Section 9(c) if payments under Section 9(c) have not
yet commenced as of the date of the Change in Control .

 

7.             Except
as expressly amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions
thereof.

 

8.             In
the event of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

* * * * * * * * * *

 

[Remainder of Page Intentionally Left Blank

Signature Page Follows.]

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF,
the parties have executed this Amendment to Executive Employment Agreement as of the Amendment Effective Date.

 

	 	THE COMPANY:
	 	 
	 	ALLIQUA BIOMEDICAL, INC.
	 	 
	 	By:	/s/ Jerome B. Zeldis
	 	Name:	Jerome B. Zeldis
	 	Title:	Chairman of the Board
	 	 	 
	 	EXECUTIVE:
	 	 	 
	 	/s/ David Johnson
	 	David Johnson

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]